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Endoplasmic reticulum (ER) stress is a hallmark of
advanced atherosclerosis, but its causative role in
plaque progression is unknown. In vitro studies
have implicated the ER stress effector CHOP in
macrophage apoptosis, a process involved in plaque
necrosis in advanced atheromata. To test the effect
of CHOP deficiency in vivo, aortic root lesions of
fat-fed Chop+/+;Apoe/ and Chop/;Apoe/
mice were analyzed for size and morphology.
Despite similar plasma lipoproteins, lesion area was
35% smaller in Chop/;Apoe/ mice. Most
importantly, plaque necrosis was reduced by 50%
and lesional apoptosis by 35% in the CHOP-deficient
mice. Similar results were found in fat-fed Chop/;
Ldlr/ versus Chop+/+;Ldlr/mice. Thus, CHOP
promotes plaque growth, apoptosis, and plaque
necrosis in fat-fed Apoe/ and Ldlr/ mice.
These data provide direct evidence for a causal link
between the ER stress effector CHOP and plaque
necrosis and suggest that interventions weakening
this arm of the UPR may lessen plaque progression.
INTRODUCTION
Understanding how asymptomatic atherosclerotic lesions are
converted into plaques that are at high risk to trigger acute
lumenal thrombosis is a major goal of molecular cardiology.
These so-called ‘‘vulnerable’’ plaques are characterized by large
necrotic cores, focal thinning of the fibrous cap, a high level of
inflammatory cytokines and matrix proteases, and apoptosis of
intimal cells (Libby et al., 1996; Kolodgie et al., 2004; Clarke
and Bennett, 2006). This latter process is critical, because
advanced lesional macrophage apoptosis, coupled with defec-
tive phagocytic clearance, results in postapoptotic necrosis
(Tabas, 2005; Schrijvers et al., 2007). Likewise, smooth muscle
cell apoptosis can lead to fibrous cap thinning (Clarke and474 Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc.Bennett, 2006), and endothelial apoptosis may promote a pro-
thrombotic state and vascular dysfunction (Choy et al., 2001).
Recent studies in vitro have implicated a signal transduction
pathway called the unfolded protein response (UPR) in the death
of all three cell types. The UPR is normally a repair pathway that
responds to a variety of perturbations that affect endoplasmic
reticulum (ER) homeostasis (Kaufman, 2002; Ron, 2002; Ma
and Hendershot, 2001). However, a particular branch of the
UPR involving the transcription factor CHOP (GADD153) can
trigger apoptosis in the setting of severe or prolonged ER stress
(Zinszner et al., 1998; Feng et al., 2003a; Lin et al., 2007). Over
the last several years, mechanistic studies with cultured cells
and analyses of mRNA and protein expression in murine and
human atheromata have suggested roles for the UPR in general
and CHOP in particular in intimal cell apoptosis (Feng et al.,
2003a, 2003b; Hossain et al., 2003; Zhou et al., 2005; Gargalovic
et al., 2006; Myoishi et al., 2007; Pedruzzi et al., 2004; Sanson
et al., 2009). For example, CHOP plays a role in macrophage
apoptosis induced by combinations of ER stressors and pattern
recognition receptor (PRR) ligand (Feng et al., 2003a; DeVries-
Seimon et al., 2005). In these studies, deletion of CHOP blocked
apoptosis without leading to ‘‘default’’ necrosis (Feng et al.,
2003a). In vivo significance is suggested by studies showing
elevated levels of mRNA and protein of UPR effectors, including
CHOP, in advanced murine aortic root and human coronary
artery plaques (Feng et al., 2003a; Zhou et al., 2005; Gargalovic
et al., 2006; Myoishi et al., 2007; Sanson et al., 2009). For
example, Myoishi et al. found a very strong correlation between
expression of UPR markers, including CHOP, and plaque
necrosis and rupture in human coronary artery lesions (Myoishi
et al., 2007). In this regard, a large number of molecules or
processes that are known to exist in advanced plaques are
UPR inducers, including oxidized lipids, homocysteine, oxidative
stress, and insulin resistance (Gargalovic et al., 2006; Hossain
et al., 2003; Han et al., 2006).
Despite this large body of correlative data, there are no studies
testing the causal relationship between CHOP expression and
the development of atherosclerotic lesions in vivo. Here, we
report that advanced aortic root lesions of both Chop/;
Apoe/ mice and Chop/;Ldlr/ fed an atherogenic diet
are smaller in total area and, most importantly, have substantially
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Reduced Plaque Necrosis in CHOP-Deficient MiceFigure 1. Total Body Weight, Plasma Lipoproteins, and CHOP Expression in Chop+/+;Apoe/ and Chop/;Apoe/ Mice
(A and B) Body weight and total plasma cholesterol of Western diet-fed male Chop+/+;Apoe/ and Chop/;Apoe/ mice (n = 20 and 21, respectively).
(C) Pooled plasma samples were subjected to fast performance liquid chromatography gel filtration, and the fractions were assayed for cholesterol concentration.
None of the differences between the two groups of mice in (A)–(C) were statistically significant.
(D) Peritoneal macrophages from Chop+/+;Apoe/ and Chop/;Apoe/ mice were loaded with lipoprotein-derived unesterified cholesterol for the
indicated times, and then whole-cell lysates were subjected to immunoblot analysis for CHOP and, as a loading control, tubulin.
(E) RNA from the intima of aortic root lesions of Chop+/+;Apoe/ and Chop/;Apoe/ mice (Figure 2) was captured by LCM, and Chop and Cypa mRNA
were quantified by RT-QPCR. Relative expression was normalized to Cypa. Results are displayed as the mean ± SEM (n = 3 RT-PCR replicates). **, Chop mRNA
not detected. Error bars indicate standard errors.diminished plaque necrosis and less intimal cell apoptosis than
the lesions of these mice with normal CHOP expression.
RESULTS
Chop+/+;Apoe/ and Chop/;Apoe/ mice on the
C57BL6 background were placed on a Western-type diet at age
8 weeks and maintained on this diet for an additional 10 weeks.
The mice were then sacrificed and analyzed for lipoprotein, meta-
bolic, and plaque characteristics. As shown in Figures 1A–1C, the
two groups of mice did not differ significantly in body weight, total
plasma cholesterol, or fasting lipoprotein profile. Moreover,
plasma triglycerides, glucose, and insulin did not differ signifi-
cantly between the two groups of mice (data not shown). As ex-
pected, peritoneal macrophages from the Chop+/+;Apoe/
mice expressed CHOP when loaded with lipoprotein-derived
unesterified cholesterol (Feng et al., 2003a), while macrophages
from the Chop/;Apoe/ did not (Figure 1D). To determine
CHOP expression in plaques, we quantified Chop mRNA using
RT-QPCR of samples obtained by laser capture microdissection(LCM) of nonendothelial intimal cells. On average, greater than
70% of the intimal cells were F4/80-positive macrophages. This
technique was used because CHOP immunohistochemistry
gives nonspecific staining in atheromata (I.T. and C. Devlin,
unpublished data). As shown in Figure 1E, Chop mRNA was
readily detected in the lesions of Chop+/+;Apoe/ mice but
not in the lesions of Chop/;Apoe/mice.
Atherosclerotic lesions were analyzed at the aortic root. As
shown in the representative images and quantitative data in
Figure 2A, lesion area was 35% less in Chop/;Apoe/
mice compared with Chop+/+;Apoe/mice (p < 0.05). In vitro,
macrophages from Chop+/ mice were equally susceptible to
FC-induced apoptosis as those from Chop+/+ mice (I.T. and
B. Feng, unpublished data). Consistent with these findings, aortic
root lesion area of Apoe/;Chop+/+ and Apoe/;Chop+/
mice were statistically indistinguishable (data not shown).
In human atherosclerotic cardiovascular disease, plaque
morphology is a more important predictor of plaque disruption
and acute clinical events than plaque size (Brown et al., 1993).
In particular, the size of the necrotic core of advanced plaquesCell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc. 475
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Reduced Plaque Necrosis in CHOP-Deficient MiceFigure 2. Reduction in Aortic Root Lesion Area and Necrotic Area in Chop/;Apoe/ Mice
(A) The images show representative sections of aortic roots from each group of mice stained with hematoxylin and eosin. Quantification was conducted on lesions
from 20 Chop+/+;Apoe/ mice and 21 Chop/;Apoe/ mice. *, p = 0.03.
(B) Representative sections of hematoxylin and eosin-stained aortic root sections from Chop+/+;Apoe/ and Chop/;Apoe/ mice (* = necrotic areas).
The bar graph shows quantification of anuclear, afibrotic, and eosin-negative necrotic areas (n = 20 for both groups of mice). **, p < 0.01.
(C) Quantification of necrotic area in a subgroup of 12 Chop+/+;Apoe/ lesions and 10 Chop/;Apoe/ lesions with statistically identical lesion area. *,
p = 0.039. Error bars indicate standard errors.is a key determinant of plaque vulnerability (Brown et al., 1993;
Kolodgie et al., 2004). Analysis of lesions for acellular nonfibrotic
areas revealed a clear decrease in plaque necrosis in theChop/
lesions, and quantification of this parameter for the entire cohort
of mice indicated a 46% decrease in total necrotic area in the
lesions of Chop/;Apoe/ mice (p < 0.01) (Figure 2B). To476 Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc.control for the potentially confounding influence of the decrease
in lesion area, we carried out a subgroup analysis of 12Chop+/+;
Apoe/ lesions and 10 Chop/;Apoe/ lesions with statis-
tically identical lesion area. In this subgroup, the Chop/;
Apoe/ lesions had a 36% decrease in necrosis (p = 0.039)
(Figure 2C).
Cell Metabolism
Reduced Plaque Necrosis in CHOP-Deficient MiceThe decreased plaque necrosis inChop/;Apoe/ athero-
mata could reflect a primary decrease in macrophage apoptosis
and/or increased efficiency of phagocytic clearance of the
apoptotic cells (efferocytosis) in Chop/;Apoe/ lesions
(Tabas, 2005; Schrijvers et al., 2007). Consistent with our
previous study (Feng et al., 2003a), macrophages fromChop/;
Apoe/ mice showed a 71% protection from apoptosis
induced by loading the macrophages with lipoprotein-derived
unesterified cholesterol (p < 0.01) (Figure 3A, left graph). Similar
results were found with 7-ketocholesterol (Figure 3A, middle
graph), an oxysterol and ER stressor present in advanced athe-
romata (Myoishi et al., 2007; Sanson et al., 2009). To test an ER
stress-PRR combination known to be present in atheromata, we
incubated macrophages with SIN-1, which generates peroxyni-
trite and induces ER stress in cells (Kawahara et al., 2001; Dickh-
out et al., 2005), and low-dose oxidized LDL, which is a PRR
ligand (Miller et al., 2003). At the doses used, neither SIN-1 nor
oxidized LDL alone triggered apoptosis in macrophages
(Figure 3A, right graph). However, the combination was a potent
inducer of apoptosis, and apoptosis was markedly reduced in
macrophages from CHOP-deficient mice. Regarding efferocyto-
sis, there was no statistically significant difference in the ability of
Chop+/+;Apoe/ versus Chop/;Apoe/macrophages to
engulf apoptotic macrophages, regardless of whether the
apoptotic cells were from either type of mouse (Figure 3B).
Pending assessment of efferocytosis in vivo, these combined
data are consistent with the interpretation that decreased
susceptibility to apoptosis is a cause of decreased plaque
necrosis in Chop/;Apoe/ lesions.
To directly assess apoptosis in situ, lesions from the two
groups of mice were stained by the TUNEL method to detect
apoptotic cells (Kockx, 1998). The representative images in
Figure 3C show occasional TUNEL-positive nuclei, at the
expected low frequency, in Chop+/+;Apoe/ lesions (Kockx,
1998; Feng et al., 2003b). Most importantly, lesions from
Chop/;Apoe/ mice had 35% less TUNEL-positive nuclei
than lesions from Chop+/+;Apoe/ mice (p < 0.01) (graph in
Figure 3C). Similar data were obtained using activated cas-
pase-3 as an assay for lesional apoptosis (Figure 3D). The less
robust effect of CHOP deficiency shown here compared with
the cell culture studies above likely reflects the difficultly of as-
sessing cumulative apoptotic events in vivo (see Discussion).
Cellular immunostaining showed that many of the TUNEL-posi-
tive nuclei were in macrophage-rich regions (Figure 3E), and
quantification revealed that 78% of these apoptotic cells colo-
calized with macrophages in Chop+/+;Apoe/ lesions and
72% in Chop/;Apoe/ lesions (p > 0.05) . These combined
mechanistic and lesional data are consistent with the hypothesis
that decreased macrophage apoptosis conferred by CHOP
deficiency contributes, at least in part, to a reduction in
advanced lesional plaque necrosis.
To test the effect of CHOP deficiency in a different model of
advanced atherosclerosis, Chop+/+;Ldlr/ and Chop/;
Ldlr/ mice were fed the Western diet for 12 weeks, and the
aortic root was analyzed for overall lesion size, plaque necrosis,
and TUNEL-positive cells. Fortunately, body weight, lipoprotein
levels, and lipoprotein distribution did not differ between the
Chop+/+ and Chop/ Ldlr/mice (Figure 4A). Overall lesion
area was modestly lower in the CHOP-deficient mice, butnecrotic area was decreased more substantially (Figure 4B).
TUNEL-positive nuclei and activated caspase-3-positive cells
were significantly less abundant in the macrophage-rich intimal
of the lesions of the CHOP-deficient mice (Figures 4C and 4D).
Thus, CHOP deficiency in the two most widely studied models
of murine atherosclerosis show strikingly similar effects: modest
reduction in lesion area with more substantial reduction in both
plaque necrosis and intimal apoptosis.
DISCUSSION
In humans, advanced necrotic atheromata are responsible for
acute atherothrombotic clinical events. While the mouse is not
a good model for plaque disruption and acute atherothrombosis
(Rosenfeld et al., 2002), it is a reasonable model for plaque
necrosis (Tabas, 2008). Therefore, understanding processes
that promote plaque necrosis in mice may give insight into plaque
disruption and atherothrombosis in humans. The data herein with
two separate models of advanced murine atherosclerosis,
together with correlative findings with advanced human coronary
atheromata (Gargalovic et al., 2006; Myoishi et al., 2007), suggest
that the CHOP branch of the UPR contributes significantly to
advanced atherosclerotic plaque progression. While it is theoret-
ically possible that CHOP affects macrophage apoptosis plus
a nonapoptotic process involved in plaque necrosis per se, we
hypothesize that the decrease in plaque necrosis is a direct
consequence of the decrease in apoptosis in the CHOP-deficient
mice. This hypothesis is based upon the concept that in
advanced atheromata, where efferocytosis appears to be defec-
tive, apoptosis becomes rate-limiting for postapoptotic necrosis
(Schrijvers et al., 2005, 2007; Tabas, 2005).
The concept that CHOP plays an important role in macro-
phage apoptosis in advanced atherosclerotic lesions is now sup-
ported by several experimental findings: (1) the role of CHOP in
apoptosis of ER-stressed cultured macrophages (Feng et al.,
2003a) (Figure 3A); (2) the fact that CHOP is expressed in
advanced lesional macrophages (Feng et al., 2003a; Zhou
et al., 2005; Myoishi et al., 2007); and most importantly, (3) our
data here showing decreased apoptosis in macrophage-rich le-
sional regions in two models of CHOP-deficient atherosclerosis-
prone mice. Although the presence of ER stress in advanced
atheromata is likely the major force behind CHOP expression,
it is theoretically possible that non-ER stress activators of the
phospho-eIF2a-ATF4-CHOP pathway, like amino acid starva-
tion in deep regions of the intima, may contribute as well (Bruhat
et al., 1997). Furthermore, while one might expect a somewhat
greater decrease in lesional apoptotic cells based on our cell
culture data, in situ measurements of apoptosis reflect the net
effect of apoptosis and efferocytosis or postapoptotic necrosis
rather than cumulative apoptotic events over a long period of
time, and so one can only obtain an estimate of trends in one
direction or another from these measurements. Finally, studies
to address the role of CHOP specifically in macrophages using
bone marrow transplantation is not possible due to the fact
that lethal irradiation fundamentally alters the relationship
between CHOP and atherosclerosis (E.T., G.L., and I.T., unpub-
lished data). Thus, creation of Cre-Lox models will be necessary
to address this important issue.Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc. 477
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Reduced Plaque Necrosis in CHOP-Deficient MiceFigure 3. Reduction in Peritoneal Macrophage and Aortic Root Lesional Macrophage Apoptosis in Apoe/;Chop/ Mice
(A) Left graph: macrophages from Chop+/+;Apoe/ or Chop/;Apoe/ mice were loaded with lipoprotein-derived unesterified cholesterol and then
assayed for apoptosis (*, p < 0.01). Middle graph represents macrophages incubated for 18 hr with vehicle control (0.2% ethanol) or 50 mM 7-ketocholesterol
and then assayed for apoptosis (*, p < 0.01 compared with Chop+/+;Apoe/ macrophages). Right graph represents macrophages incubated for 15 hr with
vehicle control, 50 mg/ml oxidized LDL (OxLDL), 1 mM SIN-1, or both compounds. The cells were then assayed for apoptosis (*, p < 0.01 compared
with Chop+/+;Apoe/ macrophages). In the case of cholesterol loading, 5% of apoptotic cells were PI-positive. With 7-ketocholesterol and OxLDL +
SIN-1, the percentage of PI-positive cells was > 50%, indicating advanced apoptosis, and both annexin-positive and PI-positive cells were decreased in the
CHOP-deficient macrophages.
(B) Efferocytosis assays were conducted using various combinations of peritoneal macrophages from Chop+/+;Apoe/ and Chop/;Apoe/mice, where
the macrophages served as the source of either the apoptotic cells or the efferocytes. None of the differences shown are statistically significant.
(C) Representative micrographs show less TUNEL-positive signal (red; arrows) in nuclei (blue) of aortic root lesions from Chop/;Apoe/ lesions. Bar, 10 mm.
Quantification of TUNEL-positive nuclei was conducted on lesions from 20 Chop+/+;Apoe/ mice and 21 Chop/;Apoe/ mice. *, p < 0.01.
(D) Representative micrographs show less activated caspase-3 (red; arrows) in aortic root lesions from Chop/;Apoe/ versus Chop/;Apoe/ lesions.
Bar, 10 mm. Quantification of TUNEL-positive cells was conducted on lesions from seven Chop+/+;Apoe/ mice and seven Chop/;Apoe/ mice. *,
p < 0.05.
(E) Representative sequential sections of a Chop+/+;Apoe/ lesion stained for nuclei (Hoechst), TUNEL, and macrophages. Bar, 10 mm. Error bars indicate
standard errors.478 Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc.
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Reduced Plaque Necrosis in CHOP-Deficient MiceFigure 4. Reduction in Aortic Root Lesion Area, Necrotic Area, and Apoptosis in Ldlr/;Chop/ Mice
(A) Body weight, plasma total cholesterol, plasma HDL cholesterol, and fast-protein liquid chromatogrpahy plasma cholesterol profile of 12 week Western diet-
fed maleChop+/+;Ldlr/ andChop/;Ldlr/mice (n = 12 and 17, respectively). None of the differences between the two groups of mice in these parameters
were statistically significant.
(B) Quantification of total aortic root lesion area and necrotic area of the mice described in (A). *, p < 0.05.
(C) Representative micrographs and quantification of TUNEL-positive signal (red) in nuclei (blue) of aortic root lesions fromChop/;Ldlr/ lesions. Bar, 10 mm.
*, p < 0.05.
(D) Quantification of activated caspase-3 in aortic root lesions from Chop+/+;Ldlr/ and Chop/;Ldlr/ lesions. *, p < 0.05. Error bars indicate standard
errors.While CHOP expression is pronounced in advanced athero-
sclerotic lesions, it is also expressed in early lesions, albeit in
lesser amounts (Zhou et al., 2005; Myoishi et al., 2007). Using
LCM-RT-QPCR, we found that Chop mRNA was 2.9-fold less
in lesions from Apoe/ mice fed the Western diet for 4 weeksversus 10 weeks (n = 3; p < 0.05). In the 4 week diet study, the
Chop+/+;Apoe/ and Chop/;Apoe/ lesion areas were
162,961 ± 34,288 and 159,841 ± 11,861 mm2, respectively
(n = 6 per group; p > 0.05). These early lesions had only very
small pockets of plaque necrosis, and the areas were notCell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc. 479
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Reduced Plaque Necrosis in CHOP-Deficient Micestatistically different between the two groups (data not shown).
Thus, CHOP does not appear to play a significant role in early
atherogenesis. However, the finding that CHOP deficiency did
have a modest effect on lesion area in the 10 week diet lesions
(Figures 2A and 4B) raises the possibility that CHOP plays a role
in one or more processes that promote the expansion of lesions
after they have reached the relatively early foam cell stage.
The results of this study, together with recent findings showing
expression of CHOP in advanced human atherosclerotic plaques
(Gargalovic et al., 2006; Myoishi et al., 2007), suggest that the
CHOP pathway may be a potential therapeutic target related to
the formation of dangerous atheromata. In particular, it will be
interesting to determine whether so-called chemical chaperones,
which have been successfully used in other animal models of
UPR-associated diseases (Ozcan et al., 2006), have a beneficial
effect on advanced atherosclerotic lesion progression.
EXPERIMENTAL PROCEDURES
Materials and additional methods are available in Supplemental Experimental
Procedures.
Mice and Diets
Chop/ mice (Zinszner et al., 1998) on the C57BL6/J were bred onto the
Apoe/ and Ldlr/ C57BL6/J backgrounds to generate Chop+/;
Apoe/ and Chop+/;Ldlr/ breeding pairs. According to genotyping
with a fixed whole-genome panel of 768 murine single-nucleotide polymor-
phisms, Chop/;Apoe/ mice were 97.3% C57BL6/J and Chop/;
Ldlr/ mice 99.1% C57BL6/J. Starting at 8 weeks of age, male progeny
from these breeding pairs were fed a high-fat (21.2%), high-cholesterol
(0.2%) Western-type diet (catalog #TD88137) from Harlan Teklad (Madison,
WI) for 10 weeks (Apoe/ study) or 12 weeks (Ldlr/ study).
Macrophage Apoptosis and Efferocytosis Assays
Macrophage apoptosis was induced by one of three methods: (1) loading with
lipoprotein-derived unesterified cholesterol by incubation with 100 mg/ml of
acetyl-LDL plus 10 mg/ml of the ACAT inhibitor 58-035 (Yao and Tabas,
2000; Feng et al., 2003a); (2) incubation with 50 mM 7-ketocholesterol; or (3)
incubation with the combination of 50 mg/ml oxidized LDL and 1 mM SIN-1.
Apoptosis was measured by annexin V and propidium iodide staining as
previously described (Yao and Tabas, 2000; Feng et al., 2003a). Efferocytosis
was assessed as previously described (Li et al., 2006; Thorp et al., 2008).
Briefly, macrophages were labeled for 1 hr with the fluorescent green vital stain
calcein AM and then rendered apoptotic by loading with lipoprotein-derived
unesterified cholesterol (above). Based upon quantification of annexin V-posi-
tivity in parallel plates, the apoptotic macrophages were added to monolayers
of unloaded macrophages (‘‘efferocytes’’) at a ratio of 1:1. After 45 min of
coculture, the noningested apoptotic cells were removed and the ingested
apoptotic cells quantified as described (Li et al., 2006).
Atherosclerotic Lesion Analysis
Mouse hearts were perfused in situ with saline and removed. Aortic roots were
fixed in 10% formalin, placed in biopsy cassettes, and processed in a Leica
tissue-processing machine followed by embedment in paraffin blocks.
Paraffin-embedded sections were cut serially at 6 mm intervals from the aortic
sinus and mounted on slides. Prior to section staining, sections were deparaffi-
nized in xylene and rehydrated in graded series of ethanol. For area measure-
ments and morphometric analysis, the sections were stained with Harris
hematoxylin and eosin. Total intimal lesional area was quantified by averaging
six sections that were spaced 30 mm apart, starting from the base of the aortic
root. Images were viewed and captured with a Nikon Labophot 2 Microscope
and analyzed using Image-Pro Plus software. Apoptotic cells in lesions were
detected by TUNEL after proteinase K treatment, using the In Situ Cell Death
Detection Kit, TMR red (Roche). Nuclei were counterstained with Hoechst for
5 min, and the slides were viewed and imaged by fluorescent microscopy.480 Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc.Apoptotic cells in lesions were also detected by immunostaining for activated
caspase-3 using rabbit anti-cleaved caspase-3 antibody #9661 from Cell
Signaling Technology. The sections were then incubated for 30 min with horse-
radish peroxidase-avidin conjugate using ABC Kit (Vector Laboratories),
developed with substrate diaminobenzidine, and then counterstained with
hematoxylin. Plaque necrosis was quantified by measuring the area of hema-
toxylin and eosin-negative acellular areas in the intima, as described
previously (Feng et al., 2003b). For macrophage staining, the sections were
heated in an EDTA solution, and then endogenous peroxidase was blocked
using hydrogen peroxide and methanol. Antigen blocking was performed
using immunoglobulin from the species of the secondary antibody. The
sections were then incubated with rabbit anti-macrophage antibody
(AIA31240) from Accurate Chemical and Scientific Corporation (Westbury,
NY), followed by incubation with biotinylated secondary antibody, streptavi-
din-horseradish peroxidase, and diaminobenzidine. Images were viewed
and captured using a Nikon Labophot 2 Microscope equipped with a Sony
CCD-Iris/RGB color video camera attached to a computerized imaging system
with Image-Pro Plus 3.0 software.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and
Supplemental References and can be found online at http://www.cell.com/
cellmetabolism/supplemental/S1550-4131(09)00063-1.
ACKNOWLEDGMENTS
This work was supported by NIH grants HL75662 and HL57560 to I.T.;
DK47119 and ES08681 to D.R.; and an American Heart Association, Heritage
Affiliate, postdoctoral fellowship grant to E.T.
Received: January 7, 2009
Revised: February 21, 2009
Accepted: March 5, 2009
Published: May 5, 2009
REFERENCES
Brown, B.G., Zhao, X.Q., Sacco, D.E., and Albers, J.J. (1993). Atherosclerosis
regression, plaque disruption, and cardiovascular events: a rationale for lipid
lowering in coronary artery disease. Annu. Rev. Med. 44, 365–376.
Bruhat, A., Jousse, C., Wang, X.Z., Ron, D., Ferrara, M., and Fafournoux, P.
(1997). Amino acid limitation induces expression of CHOP, a CCAAT/enhancer
binding protein-related gene, at both transcriptional and post-transcriptional
levels. J. Biol. Chem. 272, 17588–17593.
Choy, J.C., Granville, D.J., Hunt, D.W., and McManus, B.M. (2001). Endothelial
cell apoptosis: biochemical characteristics and potential implications for
atherosclerosis. J. Mol. Cell. Cardiol. 33, 1673–1690.
Clarke, M., and Bennett, M. (2006). The emerging role of vascular smooth
muscle cell apoptosis in atherosclerosis and plaque stability. Am. J. Nephrol.
26, 531–535.
DeVries-Seimon,T., Li, Y., Yao,P.M., Stone,E., Wang, Y., Davis, R.J., Flavell, R.,
and Tabas, I. (2005). Cholesterol-induced macrophage apoptosis requires
ER stress pathways and engagement of the type A scavenger receptor.
J. Cell Biol. 171, 61–73.
Dickhout, J.G.,Hossain, G.S., Pozza,L.M.,Zhou,J., Lhotak, S., and Austin, R.C.
(2005). Peroxynitrite causes endoplasmic reticulum stress and apoptosis in
human vascular endothelium: implications in atherogenesis. Arterioscler.
Thromb. Vasc. Biol. 25, 2623–2629.
Feng, B., Yao, P.M., Li, Y., Devlin, C.M., Zhang, D., Harding, H.P., Sweeney, M.,
Rong, J.X., Kuriakose, G., Fisher, E.A., et al. (2003a). The endoplasmic retic-
ulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell
Biol. 5, 781–792.
Feng, B., Zhang, D., Kuriakose, G., Devlin, C.M., Kockx, M., and Tabas, I.
(2003b). Niemann-Pick C heterozygosity confers resistance to lesional
Cell Metabolism
Reduced Plaque Necrosis in CHOP-Deficient Micenecrosis and macrophage apoptosis in murine atherosclerosis. Proc. Natl.
Acad. Sci. USA 100, 10423–10428.
Gargalovic, P.S., Gharavi, N.M., Clark, M.J., Pagnon, J., Yang, W.P., He, A.,
Truong, A., Baruch-Oren, T., Berliner, J.A., Kirchgessner, T.G., and Lusis,
A.J. (2006). The unfolded protein response is an important regulator of
inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26,
2490–2496.
Han, S., Liang, C.P., DeVries-Seimon, T., Ranalletta, M., Welch, C.L., Collins-
Fletcher, K., Accili, D., Tabas, I., and Tall, A.R. (2006). Macrophage insulin
receptor deficiency increases ER stress-induced apoptosis and necrotic
core formation in advanced atherosclerotic lesions. Cell Metab. 3, 257–266.
Hossain, G.S., van Thienen, J.V., Werstuck, G.H., Zhou, J., Sood, S.K.,
Dickhout, J.G., de Koning, A.B., Tang, D., Wu, D., Falk, E., et al. (2003).
TDAG51 is induced by homocysteine, promotes detachment-mediated pro-
grammed cell death, and contributes to the cevelopment of atherosclerosis
in hyperhomocysteinemia. J. Biol. Chem. 278, 30317–30327.
Kaufman, R.J. (2002). Orchestrating the unfolded protein response in health
and disease. J. Clin. Invest. 110, 1389–1398.
Kawahara, K., Oyadomari, S., Gotoh, T., Kohsaka, S., Nakayama, H., and
Mori, M. (2001). Induction of CHOP and apoptosis by nitric oxide in p53-
deficient microglial cells. FEBS Lett. 506, 135–139.
Kockx, M.M. (1998). Apoptosis in the atherosclerotic plaque: quantitative and
qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18, 1519–1522.
Kolodgie, F.D., Virmani, R., Burke, A.P., Farb, A., Weber, D.K., Kutys, R.,
Finn, A.V., and Gold, H.K. (2004). Pathologic assessment of the vulnerable
human coronary plaque. Heart 90, 1385–1391.
Li, Y., Gerbod-Giannone, M.C., Seitz, H., Cui, D., Thorp, E., Tall, A.R.,
Matsushima, G.K., and Tabas, I. (2006). Cholesterol-induced apoptotic
macrophages elicit an inflammatory response in phagocytes, which is partially
attenuated by the Mer receptor. J. Biol. Chem. 281, 6707–6717.
Libby, P., Geng, Y.J., Aikawa, M., Schoenbeck, U., Mach, F., Clinton, S.K.,
Sukhova, G.K., and Lee, R.T. (1996). Macrophages and atherosclerotic plaque
stability. Curr. Opin. Lipidol. 7, 330–335.
Lin, J.H.,Li,H., Yasumura,D., Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M.,
Lavail, M.M., and Walter, P. (2007). IRE1 signaling affects cell fate during the
unfolded protein response. Science 318, 944–949.
Ma, Y., and Hendershot, L.M. (2001). The unfolding tale of the unfolded protein
response. Cell 107, 827–830.
Miller, Y.I., Viriyakosol, S., Binder, C.J., Feramisco, J.R., Kirkland, T.N., and
Witztum, J.L. (2003). Minimally modified LDL binds to CD14, induces macro-
phage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.
J. Biol. Chem. 278, 1561–1568.
Myoishi,M.,Hao,H., Minamino, T.,Watanabe,K.,Nishihira,K., Hatakeyama, K.,
Asada, Y., Okada, K., Ishibashi-Ueda, H., Gabbiani, G., et al. (2007). Increasedendoplasmic reticulum stress in atherosclerotic plaques associated with acute
coronary syndrome. Circulation 116, 1226–1233.
Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O.,
Gorgun, C.Z., and Hotamisligil, G.S. (2006). Chemical chaperones reduce
ER stress and restore glucose homeostasis in a mouse model of type
2 diabetes. Science 313, 1137–1140.
Pedruzzi, E., Guichard, C., Ollivier, V., Driss, F., Fay, M., Prunet, C., Marie, J.C.,
Pouzet, C., Samadi, M., Elbim, C., et al. (2004). NAD(P)H oxidase Nox-4 medi-
ates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis
in human aortic smooth muscle cells. Mol. Cell. Biol. 24, 10703–10717.
Ron, D. (2002). Translational control in the endoplasmic reticulum stress
response. J. Clin. Invest. 110, 1383–1388.
Rosenfeld, M.E., Carson, K.G., Johnson, J.L., Williams, H., Jackson, C.L., and
Schwartz, S.M. (2002). Animal models of spontaneous plaque rupture: the
holy grail of experimental atherosclerosis research. Curr. Atheroscler. Rep.
4, 238–242.
Sanson,M.,Auge,N.,Vindis,C.,Muller,C.,Bando,Y.,Thiers,J.C.,Marachet,M.A.,
Zarkovic, K., Sawa, Y., Salvayre, R., and Negre-Salvayre, A. (2009). Oxidized low-
density lipoproteins trigger endoplasmic reticulum stress in vascular cells:
prevention by oxygen-regulated protein 150 expression. Circ. Res. 104, 328–336.
Schrijvers, D.M., De Meyer, G.R., Kockx, M.M., Herman, A.G., and Martinet, W.
(2005). Phagocytosis of apoptotic cells by macrophages is impaired in athero-
sclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1256–1261.
Schrijvers, D.M., De Meyer, G.R., Herman, A.G., and Martinet, W. (2007).
Phagocytosis in atherosclerosis: Molecular mechanisms and implications for
plaque progression and stability. Cardiovasc. Res. 73, 470–480.
Tabas, I. (2005). Consequences and therapeutic implications of macrophage
apoptosis in atherosclerosis: the importance of lesion stage and phagocytic
efficiency. Arterioscler. Thromb. Vasc. Biol. 25, 2255–2264.
Tabas, I. (2008). Mouse models of apoptosis and efferocytosis. Curr. Drug
Targets 8, 1288–1296.
Thorp, E., Cui, D., Schrijvers, D.M., Kuriakose, G., and Tabas, I. (2008). Mertk
receptor mutation reduces efferocytosis efficiency and promotes apoptotic
cell accumulation and plaque necrosis in atherosclerotic lesions of apoe/
mice. Arterioscler. Thromb. Vasc. Biol. 28, 1421–1428.
Yao, P.M., and Tabas, I. (2000). Free cholesterol loading of macrophages
induces apoptosis involving the fas pathway. J. Biol. Chem. 275, 23807–23813.
Zhou, J., Lhotak, S., Hilditch, B.A., and Austin, R.C. (2005). Activation of the
unfolded protein response occurs at all stages of atherosclerotic lesion devel-
opment in apolipoprotein E-deficient mice. Circulation 111, 1814–1821.
Zinszner,H.,Kuroda,M.,Wang, X.,Batchvarova,N.,Lightfoot,R.T., Remotti,H.,
Stevens, J.L., and Ron, D. (1998). CHOP is implicated in programmed cell death
in response to impaired function of the endoplasmic reticulum. Genes Dev. 12,
982–995.Cell Metabolism 9, 474–481, May 6, 2009 ª2009 Elsevier Inc. 481
